Citadel Advisors’s Adeptus Health Inc ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-69,607
Closed -$125K 8562
2017
Q1
$125K Sell
69,607
-414,348
-86% -$2.33M ﹤0.01% 6775
2016
Q4
$3.7M Buy
483,955
+456,987
+1,695% +$8.4M ﹤0.01% 2293
2016
Q3
$1.16M Buy
26,968
+21,542
+397% +$972K ﹤0.01% 3636
2016
Q2
$280K Sell
5,426
-45,218
-89% -$2.71M ﹤0.01% 5322
2016
Q1
$2.81M Sell
50,644
-401,491
-89% -$20.8M ﹤0.01% 2315
2015
Q4
$24.6M Buy
452,135
+136,014
+43% +$8.68M 0.03% 726
2015
Q3
$25.5M Buy
316,121
+309,321
+4,549% +$31.9M 0.02% 746
2015
Q2
$646K Sell
6,800
-1,281
-16% -$88.2K ﹤0.01% 4578
2015
Q1
$406K Sell
8,081
-4,298
-35% -$170K ﹤0.01% 5235
2014
Q4
$463K Buy
+12,379
New +$390K ﹤0.01% 4828

Other funds holding ADPT

Citadel Advisors's ADPT Position: Q2 2017 in Review

Citadel Advisors sold out of Adeptus Health Inc (ADPT) in Q2 2017, closing a stake of 69,607 shares — an estimated $125K sold.

Citadel Advisors first reported a position in ADPT in Q4 2014 and held it in 10 quarters. The position peaked at $25.5M in Q3 2015. 9 funds tracked by Wall St. Rank hold ADPT as of Q2 2017.

  • Citadel Advisors reported no remaining Adeptus Health Inc position as of Q2 2017 after selling out during the quarter.
  • Citadel Advisors sold 69,607 Adeptus Health Inc shares in Q2 2017, an estimated $125K.
  • Citadel Advisors first reported a position in Adeptus Health Inc in Q4 2014 and held it in 10 quarters.
  • Citadel Advisors's Adeptus Health Inc position peaked at $25.5M in Q3 2015.
  • 9 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q2 2017.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.